| Type | Privately-held company |
|---|---|
| Industry | Life Science, Manufacturing |
| Founded | 1999 |
| Founder(s) | Michael Comb |
| Headquarters | Danvers, Massachusetts |
| Key people | Michael Comb, President and CEO Roberto Polakiewicz, Chief Scientific Officer |
| Products | Antibodies, ELISA Kits, ChIP Kits |
| Employees | 250 — 300 |
| Subsidiaries | Cell Signaling Technology Japan, K.K. Cell Signaling Technology (China) Limited Cell Signaling Technology Europe, B.V. |
| Website | www.cellsignal.com |
Cell Signaling Technology, Inc. (CST) established in Beverly, Massachusetts in 1999, is a privately-held company which produces antibodies and related reagents used to study cell signaling pathways. CST's current corporate headquarters are located in Danvers, Massachusetts.
Contents |
Cell Signaling Technology, Inc. (CST) was founded in 1999 by scientists in the Cell Signaling group at New England Biolabs (NEB).[1]
Originally housed in the Cummings Center (Beverly, MA), CST moved to its current United States headquarters located at the former King’s Grant Inn (Danvers, MA) in late 2005.[1][2] Following extensive renovation[3], the U.S. Green Building Council has certified the current headquarters as a LEED (Leadership in Energy and Environmental Design) certified facility in 2007.[4] In 2008 and 2009, CST expanded its overseas operations, establishing subsidiary offices in the People’s Republic of China, Japan, and the Netherlands.[5][6]
Cell Signaling Technology, Inc. (CST) was named as one of the “Top 100 Places to Work” in a 2009 survey published by the Boston Globe.[7]
CST maintains a curated, web-based bioinformatics resource known as PhosphoSitePlus, which details protein phosphorylation in human, mouse and rat. Curated information also includes other post-translational modifications, such as protein acetylation, methylation and ubiquitinylation. This freely accessible, on-line resource is funded in part through support from the NIH.[8][9]